Gufic Biosciences Limited (BOM:509079)

Gufic Biosciences Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	9,811	9,440	8,198	8,067	6,906	7,792
Revenue Growth	16.70%	15.15%	1.63%	16.80%	-11.36%	59.76%
Gross Profit Gross Profit Growth	5,373	5,144	4,378	4,080	3,513	3,585
Operating Income Operating Income Growth	1,338	1,205	1,173	1,326	1,153	1,291
Net Income Net Income Growth	734.57	642.15	696.5	861.36	797.05	958.4
Earnings Per Share EPS Growth	7.32	6.40	6.95	8.74	8.22	9.89
EPS Growth	18.70%	-7.86%	-20.53%	6.33%	-16.85%	116.80%

Revenue by Geography

Chart

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	7,270	6,545	7,185	5,837	7,070
Africa Africa Growth	268.9	241.44	98.75	134.14	90.89
Asia Asia Growth	651.82	495.54	363.02	511.62	281.23
Europe Europe Growth	894.19	617.81	296.4	294.23	255.21
North America North America Growth	320.69	97.45	102.38	116.19	83.53
Australia Australia Growth	4.67	6.25	2.02	5.36	4.06
South America South America Growth	29.63	194.7	18.89	7.5	6.24
Total Total Growth	9,440	8,198	8,067	6,906	7,792

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	621.86	621.86	157.23	11.37	286.02	116.08
Total Debt Total Debt Growth	4,048	4,048	3,362	3,329	3,342	643.87
Net Cash (Debt) Net Cash Growth	-3,426	-3,426	-3,205	-3,318	-3,056	-527.79
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-34.16	-34.16	-31.96	-33.68	-31.52	-5.44

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-	451.39	1,226	-74.57	-265.87	1,062
Capital Expenditures CapEx Growth	-	-311.81	-755.26	-1,127	-1,876	-874.53
Free Cash Flow Free Cash Flow Growth	-	139.58	470.42	-1,202	-2,142	187.86
Free Cash Flow Growth	-	-70.33%	-	-	-	-74.90%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	54.77%	54.50%	53.41%	50.58%	50.87%	46.01%
Operating Margin	13.64%	12.77%	14.31%	16.44%	16.70%	16.57%
Pretax Margin	10.12%	9.17%	11.48%	14.34%	15.45%	16.28%
Profit Margin	7.49%	6.80%	8.50%	10.68%	11.54%	12.30%
FCF Margin	-	1.48%	5.74%	-14.89%	-31.01%	2.41%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 17, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	0.100	0.100	0.100	0.100	0.100	0.100
Dividend Per Share Growth	0%	0%	0%	0%	0%	0%
Dividend Yield	0.02%	0.04%	0.03%	0.03%	0.05%	0.04%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 17, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	57.52	42.88	48.44	32.96	22.70	25.18
P/FCF Ratio	302.61	197.25	71.72	-	-	128.44
PS Ratio	4.31	2.92	4.12	3.52	2.62	3.10

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error